Metabolic syndrome in Peru: Analysis of a national health survey in 2017-2018
DOI:
https://doi.org/10.35434/rcmhnaaa.2024.172.2245Keywords:
Metabolic syndrome, Cholesterol, Obesity, Adult, Risk factorsAbstract
Aim: Metabolic syndrome increases the risk of diabetes and cardiovascular disease. Recent studies on the prevalence of metabolic syndrome in Peru have focused on specific populations without national representativeness.
Material and Methods: Cross-sectional analysis of a national health survey. Metabolic syndrome was defined according to the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the International Diabetes Federation (IDF). The prevalence of metabolic syndrome was described according to sociodemographic variables, as well as its most frequent individual components and their predicted cardiovascular risk.
Results: We included 917 participants aged 18-59 years. The prevalence of metabolic syndrome was 46% according to the NCEP ATP III criteria and 57% according to the IDF criteria. According to both criteria, prevalence of metabolic syndrome was higher in women, people aged 40-59 years, and people from urban areas. ~60% of the population with metabolic syndrome met 3 criteria, and 96% had low HDL, 79% hyperglycemia, and 77% abdominal obesity. The predicted cardiovascular risk was higher in those meeting all 5 criteria (3,9%) than 3 criteria (1.8%).
Conclusions: Metabolic syndrome affects 1 in 2 adults in Peru and is more frequent in women, older people, and urban population. Of every 10 Peruvians with metabolic syndrome, 6 meet 3 components and only 1 meet all 5 components. The most frequent components are low HDL, hyperglycemia, and abdominal obesity.
Downloads
Metrics
References
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204–22.
United Nations. Goal 3 | Ensure healthy lives and promote well-being for all at all ages [Internet]. [cited 2022 Feb 6]. Available from: https://sdgs.un.org/goals/goal3
Organización Panamericana de Salud. ASSA2030 - Objetivo 9 | OPS/OMS | Organización Panamericana de la Salud [Internet]. 2017 [cited 2023 Jun 17]. Available from: https://www.paho.org/es/assa2030-objetivo-9
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998 Jul;15(7):539–53.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009 Jun;2(5–6):231–7.
NCD Risk Factor Collaboration (NCD-RisC)—Americas Working Group. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet Glob Health. 2020 Jan;8(1):e123–33.
Carrillo-Larco RM, Bernabé-Ortiz A. [Type 2 diabetes mellitus in Peru: a systematic review of prevalence and incidence in the general population]. Rev Peru Med Exp Salud Publica. 2019;36(1):26–36.
Chávez V, E J. Prevalencia de sobrepeso y obesidad en el Perú. Revista Peruana de Ginecología y Obstetricia. 2017 Oct;63(4):593–8.
Soto C V, Vergara W E, Neciosup P E. Prevalencia y Factores de Riesgo de Síndrome Metabólico en Población adulta del Departamento de Lambayeque, Perú - 2004. Revista Peruana de Medicina Experimental y Salud Publica. 2005 Oct;22(4):254–61.
Lopez YOT, Zambrano GMC, Ríos E del SG, Villacorta JEV, Yanet GAO. Perfil clínico-epidemiológico del síndrome metabólico en adultos atendidos en el hospital I Florencia de Mora EsSALUD. Horizonte Médico (Lima). 2020 Dec 29;20(4):e1168–e1168.
Herrera-Enriquez K, Narvaez-Guerra O. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S359–64.
Ninatanta-Ortiz JA, Núñez-Zambrano LA, García-Flores SA, Romaní Romaní F. Frecuencia de síndrome metabólico en residentes de una región andina del Perú. Revista Peruana de Medicina Experimental y Salud Publica. 2016 Oct;33(4):640–50.
Benziger CP, Bernabé-Ortiz A, Gilman RH, Checkley W, Smeeth L, Málaga G, et al. Metabolic Abnormalities Are Common among South American Hispanics Subjects with Normal Weight or Excess Body Weight: The CRONICAS Cohort Study. PLoS One. 2015;10(11):e0138968.
Chirinos DA, Morey-Vargas OL, Goldberg RB, Chirinos JA, Medina-Lezama J. Metabolic syndrome in andean populations. Glob Heart. 2013 Dec;8(4):349-354.e1.
Baracco R, Mohanna S, Seclén S. A comparison of the prevalence of metabolic syndrome and its components in high and low altitude populations in Peru. Metab Syndr Relat Disord. 2007;5(1):55–62.
Aschner P, Aguilar-Salinas C, Aguirre L, Franco L, Gagliardino JJ, de Lapertosa SG, et al. Diabetes in South and Central America: an update. Diabetes Res Clin Pract. 2014 Feb;103(2):238–43.
Medina-Lezama J, Pastorius CA, Zea-Diaz H, Bernabe-Ortiz A, Corrales-Medina F, Morey-Vargas OL, et al. Optimal definitions for abdominal obesity and the metabolic syndrome in Andean Hispanics: the PREVENCION study. Diabetes Care. 2010 Jun;33(6):1385–8.
Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, et al. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009 Sep 26;8:52.
Adams KJ, Chirinos JL. [Prevalence of Risk Factors for Metabolic Syndrome and Its Components in Community Kitchen Users in a District in Lima, Peru]. Rev Peru Med Exp Salud Publica. 2018 Mar;35(1):39–45.
Toro-Huamanchumo CJ, Pérez-Zavala M, Urrunaga-Pastor D, De La Fuente-Carmelino L, Benites-Zapata VA. Relationship between the short stature and the prevalence of metabolic syndrome and insulin resistance markers in workers of a private educational institution in Peru. Diabetes Metab Syndr. 2020 Oct;14(5):1339–45.
Sanchez-Samaniego G, Mäusezahl D, Carcamo C, Probst-Hensch N, Verastegui H, Maria Hartinger S. Metabolic syndrome in rural Peruvian adults living at high altitudes using different cookstoves. PLoS One. 2022;17(2):e0263415.
Centro Nacional de Alimentación y Nutrición. ESTADO NUTRICIONAL EN ADULTOS DE 18 A 59 AÑOS, PERÚ: 2017 - 2018 [Internet]. Lima: CENAN; 2021. Available from: https://cdn.www.gob.pe/uploads/document/file/4527291/Informe%20Tecnico-%20Estado%20nutricional%20en%20adultos%20de%2018%20a%2059%20a%C3%B1os%2CVIANEV%202017-2018G6aBA.pdf?v=1683566457
International Diabetes Federation. IDF Consensus Worldwide Definition of the Metabolic Syndrome [Internet]. 2006 [cited 2022 May 17]. Available from: https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957–80.
WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019 Oct;7(10):e1332–45.
Peiris D, Ghosh A, Manne-Goehler J, Jaacks LM, Theilmann M, Marcus ME, et al. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data. PLoS Med. 2021 Mar;18(3):e1003485.
Guzman-Vilca WC, Quispe-Villegas GA, Váscones Román FF, Bernabe-Ortiz A, Carrillo-Larco RM. Agreement between the laboratory based and non-laboratory-based WHO cardiovascular risk charts: a cross-sectional analysis of a national health survey in Peru. BMJ Open. 2022 Nov 7;12(11):e063289.
Seo Y, Kim JS, Park ES, Ryu E. Assessment of the awareness and knowledge of cancer survivors regarding the components of metabolic syndrome. PLoS One. 2018;13(6):e0199142.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143–421.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486–97.
Gobierno del Perú. Conocer establecimientos de salud del Primer Nivel de Atención [Internet]. 2022 [cited 2022 May 17]. Available from: https://www.gob.pe/16727
Després JP. CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators? Int J Obes (Lond). 2008 May;32 Suppl 2:S1-4.
Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007 Jan 30;49(4):403–14.
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Sep 28;56(14):1113–32.
World Health Organization. HEARTS Technical package for cardiovascular disease management in primary health care [Internet]. 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/333221/9789240001367-eng.pdf
Congreso de la República. Ley N.° 30021 [Internet]. 2013 [cited 2024 Feb 21]. Available from: https://www.gob.pe/institucion/congreso-de-la-republica/normas-legales/118470-30021
EsSalud. Guía de práctica clínica para el manejo de la hipertensión arterial esencial - GPC [Internet]. 2022 [cited 2024 May 14]. Available from: https://gpc-peru.com/hipertension
Ministerio de Salud del Perú. Guía Técnica: Guía de Práctica Clínica para el Diagnóstico, Tratamiento y Control de la Enfermedad Hipertensiva [Internet]. 2015 [cited 2024 May 14]. Available from: https://www.gob.pe/institucion/minsa/normas-legales/195692-031-2015-minsa
Ministerio de Salud del Perú. Guía de práctica clínica para el diagnóstico, tratamiento y control de la diabetes mellitus tipo 2 en el primer nivel de atención [Internet]. 2016 [cited 2024 Apr 9]. Available from: https://www.gob.pe/institucion/minsa/informes-publicaciones/305915-guia-de-practica-clinica-para-el-diagnostico-tratamiento-y-control-de-la-diabetes-mellitus-tipo-2-en-el-primer-nivel-de-atencion
EsSalud. Guía de práctica clínica de diabetes mellitus tipo 2 para el primer nivel de atención [Internet]. Seguro Social de Salud (EsSalud); 2010 [cited 2024 May 14]. Available from: https://repositorio.essalud.gob.pe/handle/20.500.12959/876
Ministerio de Salud del Perú. Guía Técnica para la Identificación, Tamizaje y Manejo de Factores de Riesgo Cardiovasculares y de Diabetes Mellitus Tipo 2 [Internet]. 2017 [cited 2024 May 14]. Available from: https://www.gob.pe/institucion/minsa/normas-legales/187945-1120-2017-minsa
EsSalud. DOCUMENTO TECNICO: LINEAMIENTOS GENERALES PARA EL MANEJO DEL INDICADOR DETECCION PRECOZ E INTERVENCION DEL SINDROME METABOLICO [Internet]. 2012. Available from: https://www.essalud.gob.pe/downloads/gcps/programa_de_reforma_de_vida/Normatividad/Lineamientos_Generales_de_Reforma_de_Vida.pdf
Seclén S, Villena A, Larrad MT, Gamarra D, Herrera B, Pérez CF, et al. Prevalence of the metabolic syndrome in the mestizo population of Peru. Metab Syndr Relat Disord. 2006;4(1):1–6.
Pajuelo J, Sánchez J. El síndrome metabólico en adultos, en el Perú. Anales de la Facultad de Medicina. 2007 Mar;68(1):38–46.
Cárdenas Quintana H, Sánchez Abanto J, Roldán Arbieto L, Mendoza Tasayco F. Prevalencia del síndrome metabólico en personas a partir de 20 años de edad: Perú, 2005. Revista Española de Salud Pública [Internet]. 2009 Apr [cited 2024 May 16];83(2):257–65. Available from: https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1135-57272009000200009&lng=es&nrm=iso&tlng=es
Centro Nacional de Alimentación y Nutrición. Encuesta de indicadores Nutricionales Bioquimicos (ENINB) [Internet]. 2006 [cited 2024 May 16]. Available from: https://www.gob.pe/institucion/ins/informes-publicaciones/4202622-encuesta-de-indicadores-nutricionales-bioquimicos-eninb
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016 Apr 9;387(10027):1513–30.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017 Dec 16;390(10113):2627–42.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 Oct 25;112(17):2735–52.
Tabatabaei-Malazy O, Saeedi Moghaddam S, Rezaei N, Sheidaei A, Hajipour MJ, Mahmoudi N, et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions. PLoS One. 2021;16(3):e0241926.
Pérez-Galarza J, Baldeón L, Franco OH, Muka T, Drexhage HA, Voortman T, et al. Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study. J Endocrinol Invest. 2021 Jan;44(1):63–74.
Ministerio de Salud de Chile. INFORME ENCUESTA NACIONAL DE SALUD 2016-2017 | Riesgo cardiovascular [Internet]. 2018 [cited 2024 May 17]. Available from: https://epi.minsal.cl/wp-content/uploads/2021/06/Informe_RCV_ENS_2016_17.pdf
de Siqueira Valadares LT, de Souza LSB, Salgado Júnior VA, de Freitas Bonomo L, de Macedo LR, Silva M. Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: a systematic review and meta-analysis. BMC Public Health. 2022 Feb 16;22(1):327.
Pérez-Galarza J, Baldeón L, Franco OH, Muka T, Drexhage HA, Voortman T, et al. Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study. J Endocrinol Invest. 2021 Jan;44(1):63–74.
Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022 Jun;188:109924.
Auriemma RS, Pirchio R, Liccardi A, Scairati R, Del Vecchio G, Pivonello R, et al. Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health. J Endocrinol Invest. 2021 Dec;44(12):2845–7.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Wilmer Cristobal Guzman-Vilca, Rodrigo M. Carrillo-Larco
This work is licensed under a Creative Commons Attribution 4.0 International License.
